RDY · Dr. Reddy's Laboratories Ltd ADR
United States · RS rating 84 · As of 2026-11-03
| Price | 14.30 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 91 / 88 / 58 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 32 / 31 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | -15.8% |
| Sales growth Q/Q | -0.9% |
| Distance from 52-week high | +7.0% |
| Market cap (USD) | $11.3B |